II. Definitions
- Apheresis
- General term describing the modification of one or several blood components (e.g. Platelets, WBCs) from a donor patient
- Blood is separated into individual components, and one or more specific components are removed or modified
- Remainder of the blood is then returned to donor patient after component modification
- Apheresis is typically performed via central venous access
- Plasmapheresis
- Type of Apheresis in which plasma is separated from other blood components and modified
- Plasmapharesis may be used to remove autoantibodies, immune complexes or toxins
- Plasmapheresis indications include Guillain Barre Syndrome and Myasthenia Gravis
- Leukapheresis
- Type of Apheresis in which White Blood Cells (WBCs) are removed from a donor patient's blood
- Remainder of the blood is returned to the donor patient
- Leukapheresis indications (examples)
- Hyperleukocytosis (Acute Leukemia, esp. Acute Myeloid Leukemia or AML)
- Leukostasis
- Plasma Exchange (Platepharesis, PLEX)
- Type of Plasmapheresis in which patient donor plasma is replaced with other fluids (e.g. FFP, PPF, albumin, Dextran, saline)
- Plasma Exchange may be used remove specific antibodies, immune complexes or toxins
- Plasma Exchange indications (examples)
- Thrombotic Thrombocytopenic Purpura (TTP, remove Von Willebrand Factor large multimers)
- Hyperviscosity Syndrome (remove excess Proteins)
- Exchange Transfusion
- Type of Apheresis in which a patient's Red Blood Cells (RBCs) are replaced with a donor's RBCs
- Exchange Transfusion indications (examples)
III. References
- Bierowski and Nyalakonda (2025) Crit Dec Emerg Med 39(6): 4-21